November 8, 2017

BriaVax Breast Cancer Vaccine Development Going According to Plan, Company Says

News

BriaCell Therapeutics’ Phase 1/2a study of the breast cancer vaccine BriaVax is proceeding according to plan, the company recently announced. Six patients with advanced breast cancer have received the therapeutic ... Read more

November 2, 2017November 2, 2017

‘Rollover’ Trial to Test Breast Cancer Vaccine, BriaVax, in Combo with Yervoy or Keytruda

News

A “rollover” clinical trial of BriaVax — used in combination with Keytruda (pembrolizumab) or Yervoy (ipilimumab) — will soon begin to treat women with advanced breast cancer who did not respond ... Read more